These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8203841)

  • 21. Antibiotic Therapy of Plague: A Review.
    Sebbane F; Lemaître N
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34065940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.
    Heine HS; Hershfield J; Marchand C; Miller L; Halasohoris S; Purcell BK; Worsham PL
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1919-21. PubMed ID: 25583720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicopy suppressor screening approach as a means to identify antibiotic resistance determinant candidates in Yersinia pestis.
    Stirrett KL; Ferreras JA; Rossi SM; Moy RL; Fonseca FV; Quadri LE
    BMC Microbiol; 2008 Jul; 8():122. PubMed ID: 18644132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment].
    Ryzhko IV; Tsuraeva RI; Alekseeva LP; Shcherbaniuk AI; Mishan'kin MB
    Antibiot Khimioter; 2003; 48(3):21-5. PubMed ID: 12914117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
    Zurabyan VA; Pavlovich NV; Makarovskaya LN; Ryzhkova VV; Bugaeva OK
    Antibiot Khimioter; 1997; 42(11):22-5. PubMed ID: 9463297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of oily chloramphenicol depot injection to treat plague in a murine model.
    Rahalison L; Guiyoule A; Bonacorsi SP; Slacanin I; Chanteau S; Carniel E
    J Antimicrob Chemother; 2000 Apr; 45(4):541-5. PubMed ID: 10747836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania.
    Lyamuya EF; Nyanda P; Mohammedali H; Mhalu FS
    J Trop Med Hyg; 1992 Oct; 95(5):335-8. PubMed ID: 1404556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Adamovicz JJ; Amemiya K; Fast RL; Miller L; Opal SM; Palardy J; Parejo NA; Sörgel F; Kinzig-Schippers M; Drusano GL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3276-84. PubMed ID: 24687492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].
    Ryzhko IV; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2009; 54(5-6):37-40. PubMed ID: 20052916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Gentamicin Concentration and Exposure Time on Intracellular
    VanCleave TT; Pulsifer AR; Connor MG; Warawa JM; Lawrenz MB
    Front Cell Infect Microbiol; 2017; 7():505. PubMed ID: 29312891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
    Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
    Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA
    Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.
    Mwengee W; Butler T; Mgema S; Mhina G; Almasi Y; Bradley C; Formanik JB; Rochester CG
    Clin Infect Dis; 2006 Mar; 42(5):614-21. PubMed ID: 16447105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic sensitivity of plague microbe strains from foreign countries].
    Galenko GN; Akiev AK; Tarasova VE
    Antibiot Khimioter; 1992 Nov; 37(11):23-4. PubMed ID: 1300928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.